人類病毒病抗體治療,英文原版,本人付費購得。Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v
Contributors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix
Therapeutic Control of Hepatitis C Virus:
The Role of Neutralizing Monoclonal Antibodies. . . . . . . . . . . . . . . . . . . . . 1
Z.Y. Keck, K. Machida, M.M.C. Lai, J.K. Ball, A.H. Patel,
and S.K.H. Foung
Antibodies for HIV Treatment and Prevention:
Window of Opportunity? . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 39
M. Huber, W.C. Olson, and A. Trkola
Human Monoclonal Antibody and Vaccine Approaches
to Prevent Human Rabies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 67
T. Nagarajan, Charles E. Rupprecht, Scott K. Dessain,
P.N. Rangarajan, D. Thiagarajan, and V.A. Srinivasan
Immunoprophylaxis of RSV Infection: Advancing
from RSV-IGIV to Palivizumab and Motavizumab. . . . . . . . . . . . . . . . . . . 103
H. Wu, D.S. Pfarr, G.A. Losonsky, and P.A. Kiener
The Molecular Basis of Antibody Protection Against
West Nile Virus . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 125
E. Mehlhop and M.S. Diamond
Exploring the Native Human Antibody Repertoire
to Create Antiviral Therapeutics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
S.K. Dessain, S.P. Adekar, and J.D. Berry
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 185
![Human Antibody Therapeutics for Viral Disease (springer 2008年版)]()
human antibody.jpg
[ Last edited by 1949stone on 2013-7-15 at 08:09 ] |